Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator

NATerminatedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Ventricular Tachycardia
Interventions
DRUG

amiodarone

The dosage of antiarrhythmic medications will comply with the ACC/AHA 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

DRUG

sotalol

The choice and dosage of antiarrhythmic medications will comply with the ACC/AHA 2006 Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

DEVICE

Biosense Webster's NAVI-STAR Thermo-Cool

The only ablation catheter that will be allowed in this study will be the Biosense Webster's NAVI-STAR Thermo-Cool catheter as it is the only catheter that has been approved by the FDA for sustained monomorphic VT due to prior myocardial infarction in adults.

Trial Locations (5)

15237

University of Pittsburgh Medical Center, Pittsburgh

17033

Penn State Milton S. Hershey Medical Center, Hershey

21287

Johns Hopkins Hospital, Baltimore

27710

Duke University Medical Center, Durham

43210

Ohio State University Medical Center, Columbus

Sponsors
All Listed Sponsors
collaborator

Duke Clinical Research Institute

OTHER

lead

Duke University

OTHER

NCT01576042 - Pilot Study of Catheter Ablation for Ventricular Tachycardia in Patients With an Implantable Cardioverter Defibrillator | Biotech Hunter | Biotech Hunter